stlplace

(Spreadtrum A/R and inventory from 4Q 06 to 2Q 08, click to enlarge)
As shown in the picture above, their A/R (account receivable) jumped from $1.4 m on Mar 31 to 17.4 m June 30; inventory did not reduced much. This is also evident from its reduced cash postion. Read more details from its earning release […]

I felt lucky I did sell some Spreadtrum (Nasdaq:SPRD) shares a short while ago when it exceeded $6 (a quick pop). But I don’t know why I bought some back couple days ago at $4.48. I did not bet on earning these days, but this one had dropped quite a bit from the pop, and […]

By now it’s no secret that CROX stock failed. After it issued horrendous 2Q 08 preliminary results and full year guidance yesterday afternoon (refer to MarketWatch for more details). I don’t want to dive into the numbers and add salt to injury. I traded the stock last year until this Feb. when I realized it […]

(Update July More about the value of SPRD. Last month Datang sold its 32.1% stake in TD chip maker T3G, for 122 m CNY. This values T3G at (122m) / 32.1% = 380 m CNY. That’s $54.3 m (assume $1 = 7 CNY), and I will use that number for the TD business of […]

Obviously I pulled trigger too earlier on this one, SpreadTrum Communications (Nasdaq: SPRD).

Here is a Speadsheet which has the revenue numbers for recent quarters. I think one reason for the continued pressure is the slow cell phone market, as indicated by the shipments slowdown of MediaTek, a bigger rival of Spread.
My current plan: sell […]

Let me put up the negatives (risk, downside) first. If it still stands after all the beatings, it may work out eventually. We all know semi-conductor is a tough business, and as you may know making cell phone is a cutting throat competitive business in China.

Negatives
SpreadTrum (Nasdaq:SPRD) supplies chips to domestic cell phone makers […]

WuXi Pharma Tech (NYSE:WX) continued to slide, during my absence. One (main) concern is heavy insider selling (source: seekingalpha) lately, after the secondary offering was suspended on May 4.
I double checked the F1 filings for secondary offering (principal and selling shareholders), and found its CEO Dr. Ge Li was going to sell 8 million […]

Coule day a ago I came across this BoA (NYSE:BAC) bought CCB (China Construction Bank, Hongkong 0939) shares at dirt cheap price story from my Chinese friend StrengthTrader (English news here). After that I read this one original written by 21cbh, titled The Mystery of 70% Off of CCB Shares, here is a faster link […]

GSI Techonology
As I talked in my previous post (a while ago), this is the little semi-conductor (very fast SRAM) stock (Nasdaq: GSIT) I bought a year ago at its IPO. Since its IPO it reported two disappointing quarters at first, more recently it reported two decent quarters (Fiscal Q4, Fiscal Q3). But I sold it […]

I bought some Wuxi Pharma (NYSE:WX) shares today, last year I traded it shortly after its IPO in Aug/Sept.
Recent developments
Q4 and full year 2007 results (MSN Money): total net revenues increased 93.3% to $135.2 million (compared to 2006);
Chemsitry CRO of the year by Pfizer;
Q1 2008 results to be released on May 27;
Wuxi postponed […]